Understanding the aristolochic acid toxicities in rat kidneys with regulatory networks

IET Systems Biology

Volumn 9, Issue 4, 2015, Pages 141-146

  Wang, Yin Ying ^a   Li, Zhiguang ^b   Chen, Tao ^c   Zhao, Xing Ming ^d  

^a SHANGHAI UNIVERSITY   (China)

^b DALIAN MEDICAL UNIVERSITY   (China)

^c NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^d TONGJI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GENES; MOLECULAR DYNAMICS; RNA; TOXICITY;

ARISTOLOCHIC ACID; BIOLOGICAL PROCESS; CHRONIC RENAL FAILURE; GENE REGULATORY NETWORKS; KIDNEY FUNCTION; NATURAL PRODUCTS; NEPHROTOXICITY; REGULATORY NETWORK;

ASCORBIC ACID;

RATTUS;

ARISTOLOCHIC ACID; ARISTOLOCHIC ACID I; PROTEOME;

ANIMAL; BIOLOGICAL MODEL; COMPUTER SIMULATION; DRUG EFFECTS; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORK; KIDNEY; METABOLISM; PROCEDURES; RAT; SIGNAL TRANSDUCTION;

ANIMALS; ARISTOLOCHIC ACIDS; COMPUTER SIMULATION; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; KIDNEY; MODELS, BIOLOGICAL; PROTEOME; RATS; SIGNAL TRANSDUCTION;

EID: 84938683222     PISSN: 17518849     EISSN: None     Source Type: Journal    
DOI: 10.1049/iet-syb.2014.0057     Document Type: Article

References (42)

1. Vanhaelen, M., Vanhaelen-Fastre, R., But, P., Vanherweghem, J.L.: 'Identification of aristolochic acid in Chinese herbs', Lancet, 1994, 343, (8890), p. 174
2. Debelle, F.D., Vanherweghem, J.L., Nortier, J.L.: 'Aristolochic acid nephropathy:a worldwide problem', Kidney Int., 2008, 74, (2), pp. 158-169
3. Arlt, V.M., Stiborova, M., Schmeiser, H.H.: 'Aristolochic acid as a probable human cancer hazard in herbal remedies: a review', Mutagenesis, 2002, 17, (4), pp. 265-277
4. Cheung, T.P., Xue, C., Leung, K., Chan, K., Li, C.G.: 'Aristolochic acids detected in some raw Chinese medicinal herbs and manufactured herbal products - a consequence of inappropriate nomenclature and imprecise labelling?', Clin. Toxicol. (Phila), 2006, 44, (4), pp. 371-378
5. Chen, Y.Y., Chiang, S.Y., Wu, H.C., et al.: 'Microarray analysis reveals the inhibition of nuclear factor-kappa B signaling by aristolochic acid in normal human kidney (HK-2) cells', Acta Pharmacol. Sin., 2010, 31, (2), pp. 227-236
6. Su, Z., Li, Z., Chen, T., et al.: 'Comparing next-generation sequencing and microarray technologies in a toxicological study of the effects of aristolochic acid on rat kidneys', Chem. Res. Toxicol., 2011, 24, (9), pp. 1486-1493
7. Zhao, X.M., Liu, K.Q., Zhu, G., et al.: 'Identifying cancer-related microRNAs based on gene expression data', Bioinformatics, 2014, 1-9
8. He, L., He, X., Lim, L.P., et al.: 'A microRNA component of the p53 tumour suppressor network', Nature, 2007, 447, (7148), pp. 1130-1134
9. Chan, J.A., Krichevsky, A.M., Kosik, K.S.: 'MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells', Cancer Res., 2005, 65, (14), pp. 6029-6033
10. Qin, G., Zhao, X.M.: 'A survey on computational approaches to identifying disease biomarkers based on molecular networks', J. Theor. Biol., 2014, 362, pp. 9-16
11. Zhao, X.M., Wang, R.S., Chen, L., Aihara, K.: 'Automatic modeling of signaling pathways by network flow model', J. Bioinf. Comput. Biol., 2009, 7, (2), pp. 309-322
12. Liu, K.Q., Liu, Z.P., Hao, J.K., Chen, L., Zhao, X.M.: 'Identifying dysregulated pathways in cancers from pathway interaction networks', BMC Bioinf., 2012, 13, p. 126
13. Liu, X., Liu, Z.P., Zhao, X.M., Chen, L.: 'Identifying disease genes and module biomarkers by differential interactions', J. Am. Med. Inf. Assoc., 2012, 19, (2), pp. 241-248
14. Liu, X., Tang, W.H., Zhao, X.M., Chen, L.: 'A network approach to predict pathogenic genes for Fusarium graminearum', PLoS One, 2010, 5, (10)
15. Edgar, R., Domrachev, M., Lash, A.E.: 'Gene expression omnibus: NCBI gene expression and hybridization array data repository', Nucleic Acids Res., 2002, 30, (1), pp. 207-210
16. Anders, S., Huber, W.: 'Differential expression analysis for sequence count data', Genome Biol., 2010, 11, (10), p. R106
17. Gao, Y., Gopee, N.V., Howard, P.C., Yu, L.R.: 'Proteomic analysis of early response lymph node proteins in mice treated with titanium dioxide nanoparticles', J. Proteomics, 2011, 74, (12), pp. 2745-2759
18. Nepusz, T., Yu, H., Paccanaro, A.: 'Detecting overlapping protein complexes in protein-protein interaction networks', Nat. Methods, 2012, 9, (5), pp. 471-472
19. Betel, D., Koppal, A., Agius, P., Sander, C., Leslie, C.: 'Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites', Genome Biol., 2010, 11, (8), p. R90
20. Zhang, H.M., Chen, H., Liu, W., et al.: 'Animal TFDB: a comprehensive animal transcription factor database', Nucleic Acids Res., 2012, 40, (Database issue), pp. D144-D149
21. Meng, F., Li, Z., Yan, J., et al.: 'Tissue-specific microRNA responses in rats treated with mutagenic and carcinogenic doses of aristolochic acid', Mutagenesis, 2014, 29, (5), pp. 357-365
22. Hermeking, H.: 'The miR-34 family in cancer and apoptosis', Cell Death Differ., 2010, 17, (2), pp. 193-199
23. Faragalla, H., Youssef, Y.M., Scorilas, A., et al.: 'The clinical utility of miR-21 as a diagnostic and prognostic marker for renal cell carcinoma', J. Mol. Diagn., 2012, 14, (4), pp. 385-392
24. Boguslawska, J., Wojcicka, A., Piekielko-Witkowska, A., Master, A., Nauman, A.:'MiR-224 targets the 3'UTR of type 1 5'-iodothyronine deiodinase possibly contributing to tissue hypothyroidism in renal cancer', PLoS One, 2011, 6, (9), p. e24541
25. Yu, H., Jiang, L., Sun, C., et al.: 'Decreased circulating miR-375: a potential biomarker for patients with non-small-cell lung cancer', Gene, 2014, 534, (1), pp. 60-65
26. He, Z., Cen, D., Luo, X., et al.: 'Downregulation of miR-383 promotes glioma cell invasion by targeting insulin-like growth factor 1 receptor', Med. Oncol., 2013, 30, (2), p. 557
27. Huang da, W., Sherman, B.T., Lempicki, R.A.: 'Bioinformatics enrichment tools:paths toward the comprehensive functional analysis of large gene lists', Nucleic Acids Res., 2009, 37, (1), pp. 1-13
28. Chen, Y.Y., Chung, J.G., Wu, H.C., et al.: 'Aristolochic acid suppresses DNA repair and triggers oxidative DNA damage in human kidney proximal tubular cells', Oncol. Rep., 2010, 24, (1), pp. 141-153
29. Chen, T., Guo, L., Zhang, L., et al.: 'Gene expression profiles distinguish the carcinogenic effects of aristolochic acid in target (kidney) and non-target (liver) tissues in rats', BMC Bioinf., 2006, 7, (Suppl 2), p. S20
30. Panzer, U., Steinmetz, O.M., Turner, J.E., et al.: 'Resolution of renal inflammation:a new role for NF-kappaB1 (p50) in inflammatory kidney diseases', Am. J. Physiol. Renal Physiol., 2009, 297, (2), pp. F429-F439
31. Liu, M.C., Lin, T.H., Wu, T.S., Yu, F.Y., Lu, C.C., Liu, B.H.: 'Aristolochic acid I suppressed iNOS gene expression and NF-kappaB activation in stimulated macrophage cells', Toxicol. Lett., 2011, 202, (2), pp. 93-99
32. Rayman, P., Uzzo, R.G., Kolenko, V., et al.: 'Tumor-induced dysfunction in interleukin-2 production and interleukin-2 receptor signaling: a mechanism of immune escape', Cancer J. Sci. Am., 2000, 6, (Suppl 1), pp. S81-S87
33. Alcalay, N.I., Sharma, M., Vassmer, D., et al.: 'Acceleration of polycystic kidney disease progression in cpk mice carrying a deletion in the homeodomain protein Cux1', Am. J. Physiol. Renal Physiol., 2008, 295, (6), pp. F1725-F1734
34. Rebhan, M., Chalifa-Caspi, V., Prilusky, J., Lancet, D.: 'GeneCards: integrating information about genes, proteins and diseases', Trends Genet., 1997, 13, (4), p. 163
35. Pruitt, K.D., Tatusova, T., Maglott, D.R.: 'NCBI reference sequences (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins', Nucleic Acids Res., 2007, 35, (Database issue), pp. D61-D65
36. Wu, X.,Weng, L., Li, X., et al.: 'Identification of a 4-microRNA signature for clear cell renal cell carcinoma metastasis and prognosis', PLoS One, 2012, 7, (5), p. e35661
37. Xu, J., Song, P., Nakamura, S., et al.: 'Deletion of the chloride transporter slc26a7 causes distal renal tubular acidosis and impairs gastric acid secretion', J. Biol. Chem., 2009, 284, (43), pp. 29470-29479
38. Eck, P., Kwon, O., Chen, S., Mian, L., Levine, M.: 'The human sodium-dependent ascorbic acid transporters SLC23A1 and SLC23A2 do not mediate ascorbic acid release in the proximal renal epithelial cell', Physiol. Rep., 2013, 1, (6), p. e00136
39. Liu, H., Brannon, A.R., Reddy, A.R., et al.: 'Identifying mRNA targets of microRNA dysregulated in cancer: with application to clear cell renal cell carcinoma', BMC Syst. Biol., 2010, 4, p. 51
40. Simoes, M.L., Hockley, S.L., Schwerdtle, T., et al.: 'Gene expression profiles modulated by the human carcinogen aristolochic acid I in human cancer cells and their dependence on TP53', Toxicol. Appl. Pharmacol., 2008, 232, (1), pp. 86-98
41. Marques, F.Z., Campain, A.E., Tomaszewski, M., et al.: 'Gene expression profiling reveals renin mRNA overexpression in human hypertensive kidneys and a role for microRNAs', Hypertension, 2011, 58, (6), pp. 1093-1098
42. Theoleyre, S., Mottier, S., Masson, D., Denis, M.G.: 'HtrA3 is regulated by 15-deoxy-Delta12,14-prostaglandin J2 independently of PPARgamma in clear cell renal cell carcinomas', Biochem. Biophys. Res. Commun., 2010, 394, (3), pp. 453-458